<?xml version="1.0"?>

<document>
	<title>Epidemiological investigations of the respiratory tract bacteriology
   in patients with cystic fibrosis.</title>

	<author>Hoiby-N.</author>

	<source>Acta-Pathol-Microbiol-Scand [B]. 1974 Aug. 82(4). P 541-50.</source>

	<abstract>Seventy patients with cystic fibrosis treated as out-patients in a
   cystic fibrosis clinic have been followed during one year by
   monthly bacteriological examinations of tracheal secretions.  The
   daily impression obtained in the laboratory is expressed by the
   mean point prevalence rate of Pseudomonas aeruginosa: 44 per cent,
   Staphylococcus aureus: 39 per cent, Haemophilus influenzae: 17 per
   cent, Diplococcus pneumoniae: 8 per cent, and miscellaneous other
   bacteria, mainly Enterobacteriaceae: 8 per cent.  The fluctuations
   of the bacteriology are described by additional epidemiological
   terms: At one or more examinations during the study (period
   prevalence rate), 90 per cent of the patients harboured St. aureus,
   64 per cent Ps. aeruginosa (mainly mucoid strains), 64 per cent H.
   influenzae, 37 per cent D. pneumoniae, and 30 per cent miscellaneous
   other bacteria, mainly Enterobacteriaceae.  This pattern was found
   in all age groups with minor age-dependent modifications, especially
   as regards Enterobacteriaceae.  Ps. aeruginosa was predominating as
   regards chronic colonization which reflects the most difficult
   therapeutic problems, the period prevalence rate being 39 per cent
   in contrast to St. aureus: 10 per cent, and H. influenzae: 1 per
   cent.  St. aureus was predominating as regards new colonization and
   recolonization which reflect the problems of prevention, the
   incidence rate of new colonization and recolonization per risk group
   being 84 per cent, followed by H. influenzae: 62 per cent, Ps.
   aeruginosa: 43 per cent, and D. pneumoniae: 30 per cent.  The
   results show that the bacteriological problems in cystic fibrosis
   are still considerable as regards therapy as well as prevention.
   Although many species may colonize the respiratory tracts of these
   patients, the main clinical problems concern Ps. aeruginosa and St.
   aureus; the reason why is discussed.</abstract>

	<majorsubject>CYSTIC-FIBROSIS: mi</majorsubject>
	<majorsubject>BACTERIA: ip</majorsubject>
	<majorsubject>BACTERIA: ip</majorsubject>
	<majorsubject>RESPIRATORY-TRACT-INFECTIONS: mi</majorsubject>

	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>CHILD-PRESCHOOL</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: th, dt</minorsubject>
	<minorsubject>STREPTOCOCCUS-PNEUMONIAE: ip</minorsubject>
	<minorsubject>ESCHERICHIA-COLI: ip</minorsubject>
	<minorsubject>FOLLOW-UP-STUDIES</minorsubject>
	<minorsubject>HAEMOPHILUS-INFLUENZAE: ip</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>INFANT</minorsubject>
	<minorsubject>RESPIRATORY-THERAPY</minorsubject>
	<minorsubject>KLEBSIELLA: ip</minorsubject>
	<minorsubject>PROTEUS: ip</minorsubject>
	<minorsubject>PSEUDOMONAS-AERUGINOSA: ip</minorsubject>
	<minorsubject>SPUTUM: mi</minorsubject>
	<minorsubject>STAPHYLOCOCCUS: ip</minorsubject>
	<minorsubject>STREPTOCOCCUS: ip</minorsubject>
	<minorsubject>SULFONAMIDES: tu</minorsubject>
	<minorsubject>TIME-FACTORS</minorsubject>
	<minorsubject>TRACHEA: mi</minorsubject>

	<reference>001   BURNS MW              LANCET                           1   270 968</reference>
	<reference>002   COWAN ST              MANUAL FOR THE IDENTIFICATION            965</reference>
	<reference>003   DIEM K                DOCUMENTA GEIGY SCIENTIFIC TA            962</reference>
	<reference>004   DOGGETT RG            IN: LAWSON D PROC 5TH INT CF         175 969</reference>
	<reference>005   DOSSETT JH            J IMMUNOL                      103  1405 969</reference>
	<reference>006   FEIGELSON J           MOD PROBL PEDIATR               10   214 967</reference>
	<reference>007   GIFFORD RM            J S CAROLINA MED ASSOC          68   204 972</reference>
	<reference>008   GUSTAFSON GT          J IMMUNOL                       98  1178 967</reference>
	<reference>009   HALBERT SP            PEDIATRICS                      26   792 960</reference>
	<reference>010   HALBERT SP            MOD PROBL PEDIATR               10   144 967</reference>
	<reference>012   HUANG NN              J PEDIATR                       59   512 961</reference>
	<reference>013   HUMPHREY JH           ADV IMMUNOL                     11    75 969</reference>
	<reference>014   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   81   298 973</reference>
	<reference>016   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   551 974</reference>
	<reference>018   IACOCCA VF            AM J DIS CHILD                 106   315 963</reference>
	<reference>019   IACOCCA VF            ARCH DIS CHILD                  43   220 968</reference>
	<reference>020   JENSEN K              THESIS                                   959</reference>
	<reference>022   KILBOURN JP           LANCET                           2   878 970</reference>
	<reference>023   LAWSON D              IN: WATT PJ                           69 970</reference>
	<reference>024   MACMAHON B            EPIDEMIOLOGY PRINCIPLES AND M            970</reference>
	<reference>025   MADDOCKS JL           LANCET                           1   793 969</reference>
	<reference>026   MARTIN RR             J IMMUNOL                      102   437 969</reference>
	<reference>027   MARTINEZ-TELLO FJ     J IMMUNOL                      101   989 968</reference>
	<reference>028   MAY JR                CHEMOTHERAPY OF CHRONIC BRONC            968</reference>
	<reference>029   MAY JR                ARCH DIS CHILD                  47   908 972</reference>
	<reference>030   MEARNS MB             ARCH DIS CHILD                  47   902 972</reference>
	<reference>031   SCHWARTZ RH           AM J DIS CHILD                 111   408 966</reference>
	<reference>032   SJOQUIST J            IN: KILLANDER J                      341 967</reference>
	<reference>033   STALENHEIM G          IMMUNOCHEMISTRY                 10   501 973</reference>

	<citation>1   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   559 974</citation>
	<citation>2   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   551 974</citation>
	<citation>3   HOIBY N               SCAND J RESPIR DIS              56    38 975</citation>
	<citation>4   BERGAN T              ACTA PATH MICROBIOL SCAND (B)   83   553 975</citation>
	<citation>5   HOFF GE               ACTA PATH MICROBIOL SCAND (B)   83   219 975</citation>
	<citation>6   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   83   328 975</citation>
	<citation>7   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   83   459 975</citation>
	<citation>8   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   83   549 975</citation>
	<citation>9   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   83   469 975</citation>
	<citation>10   WEEKE B               DAN MED BULL                    23   155 976</citation>
	<citation>11   BATTEN J              POSTGRAD MED J                  52   571 976</citation>
	<citation>12   HOIBY N               SCAND J RESPIR DIS              57    37 976</citation>
	<citation>13   HOIBY N               SCAND J RESPIR DIS              57   103 976</citation>
	<citation>14   VERON M               BULL INSTITUT PASTEUR           74   295 976</citation>
	<citation>15   WOOD RE               AM REV RESPIR DIS              113   833 976</citation>
	<citation>16   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977</citation>
	<citation>17   CLARKE CW             CLIN ALLERGY                     7   527 977</citation>
	<citation>18   PIVETTA OH            PEDIATR RES                     11  1133 977</citation>
	<citation>19   HOIBY N               SCAND J RESPIR DIS              58    65 977</citation>
	<citation>20   LAU WK                PEDIATRICS                      60   372 977</citation>
	<citation>21   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   85   107 977</citation>
	<citation>22   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   85   142 977</citation>
	<citation>23   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   85    57 977</citation>
	<citation>24   PARRY MF              J PEDIATR                       90   144 977</citation>
	<citation>25   OLLING S              SCAND J INFECT DIS            1977     7 977</citation>
	<citation>26   SCHIOTZ PO            HUM HERED                       28   293 978</citation>
	<citation>27   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   86    37 978</citation>
	<citation>28   HAMPTON KD            J CLIN MICROBIOL                 9   632 979</citation>
	<citation>29   HOIBY N               MONOGR PAEDIATR                 10   138 979</citation>
	<citation>30   PAPORISZ U            MONOGR PAEDIATR                 10    31 979</citation>
	<citation>31   FRIIS B               SCAND J INFECT DIS              11   211 979</citation>
	<citation>32   MAYBURY BA            ANTIMICROB AGENTS CHEMOTHER     15   494 979</citation>
	<citation>33   KRAUSE PJ             CURR THER RES CLIN EXP          25   609 979</citation>
	<citation>34   HOIBY N               ACTA PAEDIATR SCAND             68   495 979</citation>
	<citation>35   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   87     1 979</citation>
	<citation>36   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (B)   87   345 979</citation>
	<citation>37   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (B)   87   337 979</citation>
	<citation>38   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   87   229 979</citation>
	<citation>39   PAPORISZ U            EUR J PEDIATR                  130   259 979</citation>
	<citation>40   KILBOURN JP           PEDIATR RES                     14   259 980</citation>
	<citation>41   WOODS DE              INFECT IMMUN                    30   694 980</citation>
	<citation>42   SKOV PS               ALLERGY                         35    23 980</citation>
	<citation>43   MARTIN AJ             ARCH DIS CHILD                  55   604 980</citation>
	<citation>44   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   88   125 980</citation>
	<citation>45   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   88   275 980</citation>
	<citation>46   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981</citation>
	<citation>47   PETERSEN NT           ACTA PAEDIATR SCAND             70   623 981</citation>
	<citation>48   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   89   185 981</citation>
	<citation>49   BOYCE JR              INFECT IMMUN                    37   695 982</citation>
	<citation>50   KOCH C                ALLERGY                         37   191 982</citation>
	<citation>51   PERMIN H              ALLERGY                         37    93 982</citation>
	<citation>52   MOLLER NE             EUR J RESPIR DIS                63   130 982</citation>
	<citation>53   SZAFF M               ACTA PAEDIATR SCAND             71   821 982</citation>
	<citation>54   KRAEMER R             EUR J PEDIATR                  138   172 982</citation>
	<citation>55   BECK B                ACTA PAEDIATR SCAND SUPPL 301 1982   125 982</citation>
	<citation>56   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    33 982</citation>
	<citation>57   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    75 982</citation>
	<citation>58   KOLLBERG H            ACTA PAEDIATR SCAND SUPPL 301 1982    15 982</citation>
	<citation>59   SCHIOTZ PO            ACTA PAEDIATR SCAND SUPPL 301 1982    55 982</citation>
	<citation>60   ZIMAKOFF J            J HOSP INFECT                    4    31 983</citation>
	<citation>61   KERCSMAR CM           J ANTIMICROB CHEMOTHER          12   289 983</citation>
	<citation>62   KLINGER JD            INFECT IMMUN                    39  1377 983</citation>
	<citation>63   SCHIOTZ PO            ACTA PAEDIATR SCAND             72   283 983</citation>
	<citation>64   DORING G              J INFECT DIS                   147   744 983</citation>
	<citation>65   PRESSLER T            ACTA PAEDIATR SCAND             73   541 984</citation>
	<citation>66   LIEBERMAN MM          SURV SYNTH PATHOL RES            4   312 985</citation>
	<citation>67   SCULLY BE             REV INFECT DIS                   7  S669 985</citation>
	<citation>68   STANISLAVSKY ES       ACTA MICROBIOL HUNG             32    49 985</citation>
	<citation>69   JACQUOT J             INFECT IMMUN                    47   555 985</citation>
	<citation>70   BLUMER JL             AM J MED                        79    37 985</citation>
	<citation>71   SCHONHEYDER H         ACTA PATH MICROB IMMU SCA (B)   93   105 985</citation>
	<citation>72   TABLAN OC             J PEDIATR                      107   382 985</citation>
	<citation>73   HILL DJS              MED J AUST                     143   230 985</citation>
	<citation>74   KRIEG DP              J CLIN MICROBIOL                24   986 986</citation>
	<citation>75   RILEY TV              FEMS MICROBIOL LETTERS          33    55 986</citation>
	<citation>76   PEDERSEN SS           ACTA PAEDIATR SCAND             75   840 986</citation>

</document>
